231 related articles for article (PubMed ID: 16247044)
1. Concomitant loss of dynorphin, NARP, and orexin in narcolepsy.
Crocker A; España RA; Papadopoulou M; Saper CB; Faraco J; Sakurai T; Honda M; Mignot E; Scammell TE
Neurology; 2005 Oct; 65(8):1184-8. PubMed ID: 16247044
[TBL] [Abstract][Full Text] [Related]
2. Orexin gene therapy restores the timing and maintenance of wakefulness in narcoleptic mice.
Kantor S; Mochizuki T; Lops SN; Ko B; Clain E; Clark E; Yamamoto M; Scammell TE
Sleep; 2013 Aug; 36(8):1129-38. PubMed ID: 23904672
[TBL] [Abstract][Full Text] [Related]
3. Effects of orexin gene transfer in the dorsolateral pons in orexin knockout mice.
Blanco-Centurion C; Liu M; Konadhode R; Pelluru D; Shiromani PJ
Sleep; 2013 Jan; 36(1):31-40. PubMed ID: 23288969
[TBL] [Abstract][Full Text] [Related]
4. History of narcolepsy at Stanford University.
Mignot EJ
Immunol Res; 2014 May; 58(2-3):315-39. PubMed ID: 24825774
[TBL] [Abstract][Full Text] [Related]
5. Rewiring brain circuits to block cataplexy in murine models of narcolepsy.
Liu M; Blanco-Centurion C; Shiromani PJ
Curr Opin Neurobiol; 2017 Jun; 44():110-115. PubMed ID: 28445807
[TBL] [Abstract][Full Text] [Related]
6. The neurobiological basis of narcolepsy.
Mahoney CE; Cogswell A; Koralnik IJ; Scammell TE
Nat Rev Neurosci; 2019 Feb; 20(2):83-93. PubMed ID: 30546103
[TBL] [Abstract][Full Text] [Related]
7. [Research Progress in the Correlation Between Dopamine and Clinical Characterization of Narcolepsy].
Zhao WY; Tang JY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2024 Apr; 46(2):254-259. PubMed ID: 38686723
[TBL] [Abstract][Full Text] [Related]
8. Connecting the dots: An updated review of the role of autoimmunity in narcolepsy and emerging immunotherapeutic approaches.
Valizadeh P; Momtazmanesh S; Plazzi G; Rezaei N
Sleep Med; 2024 Jan; 113():378-396. PubMed ID: 38128432
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the Nucleus Accumbens in Chocolate-induced Cataplexy.
Su J; Li Z; Yamashita A; Kusumoto-Yoshida I; Isomichi T; Hao L; Kuwaki T
Sci Rep; 2020 Mar; 10(1):4958. PubMed ID: 32188934
[TBL] [Abstract][Full Text] [Related]
10. [Orexin].
Chibana K
Arerugi; 2023; 72(9):1176-1177. PubMed ID: 37967965
[No Abstract] [Full Text] [Related]
11. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior.
Sakurai T; Amemiya A; Ishii M; Matsuzaki I; Chemelli RM; Tanaka H; Williams SC; Richardson JA; Kozlowski GP; Wilson S; Arch JR; Buckingham RE; Haynes AC; Carr SA; Annan RS; McNulty DE; Liu WS; Terrett JA; Elshourbagy NA; Bergsma DJ; Yanagisawa M
Cell; 1998 Feb; 92(4):573-85. PubMed ID: 9491897
[TBL] [Abstract][Full Text] [Related]
12. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity.
de Lecea L; Kilduff TS; Peyron C; Gao X; Foye PE; Danielson PE; Fukuhara C; Battenberg EL; Gautvik VT; Bartlett FS; Frankel WN; van den Pol AN; Bloom FE; Gautvik KM; Sutcliffe JG
Proc Natl Acad Sci U S A; 1998 Jan; 95(1):322-7. PubMed ID: 9419374
[TBL] [Abstract][Full Text] [Related]
13. Neurons containing hypocretin (orexin) project to multiple neuronal systems.
Peyron C; Tighe DK; van den Pol AN; de Lecea L; Heller HC; Sutcliffe JG; Kilduff TS
J Neurosci; 1998 Dec; 18(23):9996-10015. PubMed ID: 9822755
[TBL] [Abstract][Full Text] [Related]
14. Orexin/hypocretin role in reward: implications for opioid and other addictions.
Baimel C; Bartlett SE; Chiou LC; Lawrence AJ; Muschamp JW; Patkar O; Tung LW; Borgland SL
Br J Pharmacol; 2015 Jan; 172(2):334-48. PubMed ID: 24641197
[TBL] [Abstract][Full Text] [Related]
15. Hindbrain Catecholamine Neurons Activate Orexin Neurons During Systemic Glucoprivation in Male Rats.
Li AJ; Wang Q; Elsarelli MM; Brown RL; Ritter S
Endocrinology; 2015 Aug; 156(8):2807-20. PubMed ID: 25978516
[TBL] [Abstract][Full Text] [Related]
16. Do Orexins contribute to impulsivity-driven binge consumption of rewarding stimulus and transition to drug/food dependence?
Alcaraz-Iborra M; Cubero I
Pharmacol Biochem Behav; 2015 Jul; 134():31-4. PubMed ID: 25931265
[TBL] [Abstract][Full Text] [Related]
17. Heterodimerization of human orexin receptor 1 and kappa opioid receptor promotes protein kinase A/cAMP-response element binding protein signaling via a Gαs-mediated mechanism.
Chen J; Zhang R; Chen X; Wang C; Cai X; Liu H; Jiang Y; Liu C; Bai B
Cell Signal; 2015 Jul; 27(7):1426-38. PubMed ID: 25866368
[TBL] [Abstract][Full Text] [Related]
18. CD4+ T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza A epitope in narcolepsy.
De la Herrán-Arita AK; Kornum BR; Mahlios J; Jiang W; Lin L; Hou T; Macaubas C; Einen M; Plazzi G; Crowe C; Newell EW; Davis MM; Mellins ED; Mignot E
Sci Transl Med; 2013 Dec; 5(216):216ra176. PubMed ID: 24353159
[TBL] [Abstract][Full Text] [Related]
19. Narcolepsy: immunological aspects.
Overeem S; Black JL; Lammers GJ
Sleep Med Rev; 2008 Apr; 12(2):95-107. PubMed ID: 18291691
[TBL] [Abstract][Full Text] [Related]
20. Differential target-dependent actions of coexpressed inhibitory dynorphin and excitatory hypocretin/orexin neuropeptides.
Li Y; van den Pol AN
J Neurosci; 2006 Dec; 26(50):13037-47. PubMed ID: 17167093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
